| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 03/15/2007 | US20070060629 Large conductance calcium-activated k channel opener |
| 03/15/2007 | US20070060583 2-tert-Butyl-N,N-diethyl-1-{[1-methylpiperidin-2-yl]methyl}-1H-benzimidazole-5-carboxamide; cannabinoid receptors agonists; analgesic, anticarcinogenic, antiinflammatory, anxiolytic agent; neurodegenerative diseases; gastrointestinal and cardiovascular disorders |
| 03/15/2007 | US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction |
| 03/14/2007 | EP1761496A2 Non-imidazole heterocyclic compounds as histamine h3-receptor ligands |
| 03/14/2007 | EP1761262A1 Marine compounds with calcium channel blocking properties for the treatment of cognitive or neurodegenerative diseases |
| 03/14/2007 | EP1163240B1 Tricyclic benzoylpyrazole derivatives used as a herbicide |
| 03/14/2007 | CN1930136A Isoxazoline-substituted benzamide compound and noxious organism control agent |
| 03/14/2007 | CN1927847A Application of isoxazole compounds as bactericide |
| 03/08/2007 | WO2007027230A2 Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
| 03/08/2007 | WO2007026965A1 Isoxazoline-substituted benzamide compound and harmful organism-controlling agent |
| 03/08/2007 | US20070054902 Isoxazole derivatives as peroxisome proliferator-activated receptors agonists |
| 03/08/2007 | US20070054900 4-Phenlthiazole and 4-phenylimidizole derivatives and their use as medicaments for the treatment of neurodegenerative diseases, pain and epilepsy |
| 03/08/2007 | US20070054897 1,1-Dicyclohexyl-3-thiazol-2-yl-urea, 3-(5-Chloro-thiazol-2-yl)-1,1-dicyclohexyl-urea, for example; useful for the management, treatment, control, or adjunct treatment of diseases, where increasing glucokinase activity is beneficial, in particular, type 2 diabetes |
| 03/08/2007 | CA2621228A1 Isoxazoline-substituted benzamide compound and pesticide |
| 03/08/2007 | CA2606106A1 Heterocyclic anti-viral compounds comprising metabolizable moieties and their uses |
| 03/07/2007 | EP1758861A1 Dpp-iv inhibitors |
| 03/07/2007 | EP1507777A4 Process for preparing crystalline form i of cabergoline |
| 03/07/2007 | EP0959076B1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics |
| 03/07/2007 | CN1926097A Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 03/06/2007 | US7186742 Benzamide inhibitors of the P2X7 receptor |
| 03/06/2007 | US7186738 antibiotics such as (5R)-3-[3-Fluoro-4-(3-methylisoxazol-5-yl)phenyl]-5-(1H-1,2,3-triazol-1-ylmethyl)-1,3-oxazolidin-2-one, having effective activity against both grampositive and gramnegative pathogens |
| 03/06/2007 | US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders |
| 03/06/2007 | US7186719 Antibacterial agents |
| 03/06/2007 | CA2168319C 4-mercaptobenzoylguanidine derivatives |
| 03/01/2007 | WO2007025303A2 Non-steroidal antiandrogens |
| 03/01/2007 | WO2007025247A2 Transglutaminase inhibitors and methods of use thereof |
| 03/01/2007 | WO2007024836A2 Preparation of tetrahydro-1,8-dioxa-4a-aza-naphthalenes and their use in coating applications |
| 03/01/2007 | WO2006138510B1 Substituted enaminones as nicotinic acetylcholine receptor modulators |
| 03/01/2007 | US20070049629 Non-Steroidal Antiandrogens |
| 02/28/2007 | EP1756058A1 Histamine-3 receptor antagonists |
| 02/28/2007 | EP1756052A1 Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
| 02/28/2007 | EP1756043A1 Ortho substituted aryl or heteroaryl amide compounds |
| 02/28/2007 | EP1756029A1 Novel compounds, the preparation and the use thereof for a regiospesific synthesis of perfluor(alkyl) group heterocycles |
| 02/28/2007 | EP1626962B1 Benzamide inhibitors of the p2x7 receptor |
| 02/28/2007 | EP1418912B1 Isoxazolopyridinones |
| 02/28/2007 | EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents |
| 02/28/2007 | EP1102753B1 Pyrazoles as estrogen receptor modulators |
| 02/28/2007 | CN1922162A Derivatives of alkylpiperazine- and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as FAAH enzyme inhibitors |
| 02/28/2007 | CN1922157A Benzo[d]isoxazol-3-ol daao inhibitors |
| 02/28/2007 | CN1301974C Muller Klaus-helmut |
| 02/28/2007 | CN1301969C New mandelic acid derivatives and their use as thrombin inhibitors |
| 02/28/2007 | CN1301968C Substituied ureaalkyl urea vitamin A protagonist ii |
| 02/28/2007 | CN1301964C Inhibitors of alpha 4 mediated cell adhesion |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183297 For therapy of rheumatoid arthritis, osteoarthritis, asthma, psoriasis, eczema, allergic rhinitis, allergic conjunctivitis, adult respiratory distress syndrome, chronic pulmonary inflammation, chronic obstructive pulmonary disease, chronic heart failure, silicosis, endotoxemia, toxic shock syndrome |
| 02/22/2007 | WO2007022529A2 Method of treating inflammatory diseases |
| 02/22/2007 | WO2007020888A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 02/22/2007 | US20070043220 {2-Methyl-4-[3-methyl-1-(4-trifluoromethyl-phenyl)-1H-pyrazol-4-ylmethylsulfanyl]-phenoxy}-acetic acid; diabetes mellitus, Metabolic Syndrome, atherosclerosis, cardiovascular diseases,Type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension |
| 02/22/2007 | US20070042996 N-alkynyl-2-(substituted aryloxy) alkylthioamine derivatives as fungicides |
| 02/22/2007 | CA2618653A1 Brain/neuronal cell-protecting agent and therapeutic agent for sleep disorder |
| 02/21/2007 | EP1754705A2 Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 02/21/2007 | EP1754475A1 Use of C-terminal modified oxamyl dipeptides as inhibitors of the ice/ced-3 family of cysteine proteases |
| 02/21/2007 | EP1753713A2 Synthesis of tetracyclines and analogues thereof |
| 02/21/2007 | EP1551798B1 Novel sulphones for inhibition of gamma secretase |
| 02/20/2007 | US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction |
| 02/20/2007 | US7179804 Tachykinin receptor antagonists |
| 02/15/2007 | US20070037973 reacting a cyclic alpha , beta -unsaturated ketone compound with a nitroso compound in the presence of a proline-based catalyst to provide 7-Phenyl-6-oxa-7-aza-bicyclo[3.2.2]nonan-9-one or derivatives; catalytic asymmetric O-nitroso Aldol/Michael reaction |
| 02/15/2007 | US20070037795 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders |
| 02/15/2007 | US20070037752 Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 02/14/2007 | EP1533292B1 Dibenzylamine compound and medicinal use thereof |
| 02/14/2007 | EP1063982B1 Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders |
| 02/14/2007 | CN1913880A Method for treating ADAMTS-5-associated disease |
| 02/13/2007 | US7176242 N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 02/08/2007 | WO2007016209A2 Pure 1,2-benzisoxazole-3-methane-sulfonic acid sodium salt and purification process |
| 02/08/2007 | WO2007016208A2 1,2-benzisoxazole-3-methane-sulfonic acid ammonium salt |
| 02/08/2007 | WO2007015533A1 Amidine compound and herbicide |
| 02/08/2007 | WO2005094329A3 Compouns, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factor |
| 02/07/2007 | EP1656348B1 Acetylene derivatives as inhibitors of histone deacetylase |
| 02/07/2007 | EP1261336B1 Il-8 receptor antagonists |
| 02/07/2007 | CN1910156A Malononitrile compound as pesticide |
| 02/06/2007 | US7173139 Enantioselective 1,4-addition of aromatic nucleophiles to α,β-unsaturated aldehydes using chiral organic catalysts |
| 02/06/2007 | US7173132 Certain substituted 1-aryl-3-piperazine-1′-yl propanones |
| 02/06/2007 | US7173052 Resorcinol for lightening skin removing color |
| 02/06/2007 | US7173035 Arylsulfonamide compounds |
| 02/06/2007 | US7172769 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 02/06/2007 | CA2362816C Valdecoxib compositions |
| 02/01/2007 | WO2007013694A1 Phenoxyalkanoic acid compound |
| 02/01/2007 | WO2006127871A3 Cycloalkylidene compounds as selective estrogen receptor modulators |
| 02/01/2007 | WO2006033891A3 Compounds for the treatment of dyslipidemia and other lipid disorders |
| 02/01/2007 | US20070027141 Derivatives of alkylpiperazine and alkylhomopiperazine-carboxylates, preparation method thereof and use of same as fatty acid amido hydrolase enzyme inhibitors |
| 01/31/2007 | EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 01/31/2007 | EP1746991A2 Daao inhibiting benzisoxazoles for treating mental disorders |
| 01/31/2007 | CN1906171A Substituted azole compounds, preparation and application thereof |
| 01/31/2007 | CN1297543C Substitued arylketones |
| 01/30/2007 | US7169939 Linkers for donor dyes to acceptor dyes for energy transfer between dyes with fluorescence |
| 01/30/2007 | US7169817 Treatment and/or prevention of diseases or disorders mediated by lymphocyte interactions. |
| 01/30/2007 | US7169797 Protein-tyrosine phosphatase inhibitors and uses thereof |
| 01/30/2007 | US7169786 Strong anti-depressant activity without being sedative; serotonin (5-HT) reuptake inhibitor activity in combination with additional alpha 2-adrenoceptor antagonist activity |
| 01/25/2007 | WO2006074330A3 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 01/25/2007 | US20070021509 Phosphate transport inhibitors |
| 01/25/2007 | US20070021426 Derivatives of heteroaryl-alkylcarbamates, methods for their preparation and use thereof as fatty acid amido hydrolase enzyme inhibitors |
| 01/25/2007 | US20070021390 thiazole, oxazole derivatives useful for treating neurodegenerative disorders or pain |
| 01/25/2007 | DE102005031583A1 Verfahren zur Herstellung von von 3-Arylmethylthio- und 3-Heteroarylmethylthio-4,5-dihydro-isoxazolin-Derivaten Process for the preparation of 3-Arylmethylthio- and 3-Heteroarylmethylthio-4,5-dihydro-isoxazoline derivatives |
| 01/24/2007 | EP1745027A1 Compounds and compositions as ppar modulators |
| 01/24/2007 | EP1745009A1 Heteroaryl substituted cyclohexyl-1,4-diamine derivatives |
| 01/24/2007 | CN1902206A Preparation of 1-aza-2-oxa-dibenzo [e,h] azulenes and their use for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders |
| 01/24/2007 | CN1901971A Cyclopropane compounds and pharmaceutical use thereof |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/23/2007 | US7166725 Benzo[d]isoxazol-3-ol DAAO inhibitors |
| 01/23/2007 | US7166627 Antibiotic compositions and methods of using the same |